New study aims to boost HIV prevention in vulnerable women

NCT ID NCT06835751

Ongoing Prevention Sponsor: Johns Hopkins Bloomberg School of Public Health Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests two counseling programs to help women who use drugs in Tanzania start and stay on PrEP, an HIV prevention pill. 200 women will be randomly assigned to receive either brief motivational counseling, the same plus extra mental health support, or standard information. The goal is to see which approach works best to overcome barriers like stigma and mental health challenges.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Motivational Interviewing for PrEP and Common Elements Treatment Approach (CETA) plus MI-PrEP
What this could lead to: If successful, this could point toward effective ways to support PrEP use among women who use drugs, reducing their HIV risk.
What could go wrong: This is a small pilot study with 200 participants, so results may not apply to all women. The interventions may not improve PrEP adherence or mental health as hoped.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Psychological Well-Being substance abuse substance-related disorder HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV MENTAL HEALTH SUBSTANCE USE (DRUGS, ALCOHOL)

Contacts and locations

Locations

Muhimbili University of Health and Allied Sciences

Dar es Salaam, Tanzania

More trials for these conditions

Other studies related to the condition(s) this trial covers.